Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
NCT ID: NCT00936845
Last Updated: 2012-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2005-04-30
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Females with Hemophilia
Females with severe or moderate Hemophilia A or B.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females with severe (FIX\<0.01u/dl) or moderate (FIX-0.01\<0.06u/dl) hemophilia B
* Willingness to participate in the study.
1 Month
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CSL Behring
INDUSTRY
University of Pennsylvania
OTHER
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William B Mitchell, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City of Hope National Medical Center
Duarte, California, United States
Mountain States Regional Hemophilia and Thrombosis Center
Aurora, Colorado, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
Emory University Hemophilia Program Office
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Kentucky Hemophilia Treatment Center
Lexington, Kentucky, United States
Boston Hemophilia Center- Children's Hospital
Boston, Massachusetts, United States
Henry Ford Hospital Adult Hemophilia and Thrombosis Treatment Center
Detroit, Michigan, United States
Newark Beth Israel Medical Center
Newark, New Jersey, United States
Hemophilia Center of Western New York - Pediatric
Buffalo, New York, United States
Long Island Jewish Medical Center
New Hyde Park, New York, United States
Weill Cornell Medical College
New York, New York, United States
Mary M. Gooley Hemophilia Center, Inc.
Rochester, New York, United States
Children's Hospital Medical Center of Akron
Akron, Ohio, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Oklahoma Center for Bleeding Disorders
Oklahoma City, Oklahoma, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas, United States
Puerto Rico Hemophilia Treatment Center
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Females with Hemophilia
Identifier Type: -
Identifier Source: org_study_id